Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Scientists Examine HIV's Effect On Immune System
A study by researchers from Duke University and the University of North Carolina-Chapel Hill and published in PLoS Medicine has found that upon infection "three lines of attack by the immune system are quickly neutralized by HIV," findings they hope "will provide a better understanding of how to develop a vaccine to protect against the virus," the Raleigh News & Observer reports. The study, lead by Duke"s Barton Haynes, showed that HIV, "once considered a slow if stealthy invader, actually works incredibly fast at disarming key immune fighters in the body." Haynes said scientists still have a difficult task in developing a vaccine, adding, "It would have to be different than any other vaccine made" (Avery, 7/7).
generic viagra online
Back-to-School Health: Are Your Child's Eyes Ready For The Classroom?
Good vision can be directly correlated with a child"s learning ability. As much as 80% of the learning a child does occurs through his eyes and approximately 1 in 4 school-age children have some type of vision impairment.
News of the day
Blogs Comment On Obama's Notre Dame Speech, Gallup Poll On Abortion Views, Other Topics
The following summarizes selected women"s health-related blog entries.~ "Nine Key Developments in Obama"s Notre Dame Speech," Dan Gilgoff, U.S. News & World Report"s God and Country: When speaking at the University of Notre Dame"s commencement ceremony Sunday, President Obama "devoted a good-sized chunk of the address to confronting the basis for the controversy" surrounding his invitation to speak "head on," Gilgoff writes. He goes on to list nine key points in the speech, including Obama"s decisions to acknowledge the controversy surrounding his appearance at the commencement; highlight his policy proposals of increasing adoption availability and assistance to pregnant women who carry pregnancies to term, which "go way beyond pregnancy prevention;" and voice his support for "drafting a sensible conscience clause," which represents a step away from completely rescinding the Bush administration provider "conscience" rule. Gilgoff writes that Obama also "argued, despite his hopes of achieving common ground around the hottest-button issue, the two sides in the abortion debate really are at loggerheads," adding that his statement was "incongruous with a speech that argued common ground is always possible between ideological combatants." Gilgoff also discusses media coverage of the event and the fact that "Obama never stated his pro-abortion-rights position," which likely will "rile" abortion-rights advocates. In addition, Obama "peppered his speech with shows of respect for those on the other side of the issue," according to Gilgoff. Lastly, Obama addressed the moral issue surrounding abortion, which "represents a break from Democrats who, for a long time, declined to do so," but also spoke on other moral and religious issues beyond abortion -- an important move "because most religious Americans don"t see their faith mostly in terms of stopping abortion" (Gilgoff, U.S. News & World Report"s God and Country, 5/18).~ "Has the Public Become More Opposed to Abortion?" John Sides, The Monkey Cage: Recently released polls from Gallup and the Pew Research Center were based on "hopelessly mushy" questions, and the "findings obscure far more than they reveal," Sides writes. The Gallup data showed that the percentage of people who said they are "pro-life" has risen and is larger than the percentage who calls themselves "pro-choice." The Pew data showed a decline in the percentage of people who think abortion should be legal in "all" or "most" cases, with an increase in the percentage of people who think it should be illegal in all or most cases. However, "a wider array of data do not appear to show notable trends," and the "movement appears to be among Republicans," Sides writes, adding that the two research groups "purport to show shifts in opinion that are not evident in other data." The two groups "employ vague questions that do not easily map onto actual policy debates," he continues, concluding, "Once more precise data are employed, it becomes clear that opinion strongly depends on the circumstances under which the abortion would occur" (Sides, The Monkey Cage, 5/16).~ "Discussion: Obama at Notre Dame," Washington Post"s On Faith: The Washington Post"s On Faith blog posted several entries regarding President Obama"s speech at the University of Notre Dame"s commencement ceremony. Susan Brooks Thistlewaite, a senior fellow at the Center for American Progress, writes that she "appreciated" that Obama"s speech "acknowledged that women are the central decision makers" when it comes to abortion "and that women engage in moral reasoning to make the decision." However, this has "kept religious authorities from making the connection between insights from the history of ethics and the abortion question." Brian McLaren, an evangelical pastor, writes that the speech "was an example of the kind of respectful discourse we need when grappling with issues over which we disagree, while author Susan Jacoby says that the speech and reaction from the audience "will h
Public Health

B. Braun Anticipates Becoming First To Deliver FDA Approved 2g Cefazolin

B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it anticipates U.S. Food and Drug Administration (FDA) approval for 2g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun"s DUPLEX(R) Drug Delivery System. The FDA approval will make B. Braun the first company to deliver an FDA approved 2g Cefazolin dose to hospitals and other healthcare settings where it is a frequently prescribed antibiotic. The arrival of 2g Cefazolin will be welcome news in hospital emergency rooms, operating suites and outpatient surgical centers. Until now, Cefazolin had only been available in 1g IV and multi-dose vials. The 2g Cefazolin in the DUPLEX(R) system can be stored, ready to use wherever and whenever it is needed, which means faster, safer and more accurate administration of 2g Cefazolin to patients. "B. Braun heard physician and pharmacist calls for a 2g Cefazolin dose and we"ve responded," said Rob Albert, Vice President, Pharma Marketing for B. Braun. "2g Cefazolin will be the latest in an expanding DUPLEX(R) portfolio, which is designed to provide fast, safe, convenient and Joint Commission and USP Chapter compliant products that improve the practice of healthcare professionals while advancing patient safety and outcomes." Frequently used in emergency rooms, operating suites and ambulatory surgery centers, B. Braun will offer 2g Cefazolin delivered via its DUPLEX(R) Delivery System, a ready-to-use two-compartment flexible plastic IV container that stores pre-measured drug and diluent doses. Healthcare workers administering DUPLEX(R) simply squeeze the container and shake it to mix pharmaceuticals and diluent. The DUPLEX(R) system saves time, labor and speeds dispensing because it can be stored right in emergency and operating rooms until it"s needed and is ready immediately. Its PVC-free construction makes it eco-friendly while its DEHP-free and Latex-free construction makes it patient-friendly. A barcode that references the final admixture, lot number and expiration date helps reduce medication errors, automate patient charting, track inventory and facilitate reimbursement tracking. With the addition of 2g Cefazolin to its drug delivery portfolio, B. Braun will expand its broad spectrum of intravenous cephalosporin antibiotic therapies for the hospital setting: Cefoxitin, CefTRIaxONE, 1g Cefazolin, CefUROXime and Cefotetan. About DUPLEX The DUPLEX(R) Drug Delivery System is a revolutionary system designed to simplify intravenous antibiotic delivery to patients, minimize the potential for medication errors, eliminate the pharmacy labor component of IV antibiotic delivery and reduce drug waste. Consisting of a pre-filled, DEHP-free, PVC-free, Latex-free IV bag containing proper doses of drug and diluent in different compartments separated by a quick release seal, DUPLEX(R) can be stored at room temperature and does not require a messy thawing process. The caregiver simply squeezes the bag to mix the drug and diluent just prior to administration. Special oxygen and moisture barrier technologies are employed to protect the drug powder from vapor and oxygen transfer through the bag over the product"s shelf life. About B. Braun B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company"s "Sharing Expertise(R)" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives. Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. Braun Medical Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009